LENSAR Inc (LNSR) vs MediciNova, Inc. (MNOV)
A side-by-side comparison of LENSAR Inc and MediciNova, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LNSR
LENSAR Inc
$6.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MNOV
MediciNova, Inc.
$1.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LNSR vs MNOV
growth of $100 · dividends reinvested · last 6yLNSR -25.9% (-4.9%/yr)MNOV -65.6% (-16.3%/yr)LNSR compounded faster over this window
LNSR MNOV
LNSR vs MNOV: by the numbers
- •LNSR is the larger company ($82M vs $81M market cap).
- •LNSR is profitable (57.57% net margin) while MNOV runs a net loss (-1168.20%).
- •LNSR grew revenue faster over the past five years (14.67% vs -25.46% CAGR).
Metrics side by side
Valuation
| Metric | LNSR | MNOV |
|---|---|---|
| P/S ratio | 1.37 | 88.23 |
| P/B ratio | 5.52 | 2.18 |
Profitability
| Metric | LNSR | MNOV |
|---|---|---|
| Gross margin | 47.96% | 7.58% |
| Operating margin | -42.06% | -3242.47% |
| Net margin | 57.57% | -1168.20% |
| ROE | 232.78% | -28.85% |
| ROIC | -16.28% | -31.62% |
Growth (annualized)
| Metric | LNSR | MNOV |
|---|---|---|
| Revenue CAGR (5Y) | 14.67% | -25.46% |
| Total return CAGR (5Y) | -3.18% | -13.62% |
Frequently asked
- Which has grown faster, LNSR or MNOV?
- Over the past five years, LNSR grew revenue faster — LNSR at a 14.67% CAGR versus MNOV at -25.46%.
- Is LNSR or MNOV more profitable?
- LNSR runs the higher net margin — LNSR at 57.57% versus MNOV at -1168.20%.
- How have LNSR and MNOV total returns compared?
- Over the past 5 years, LNSR delivered -3.18% and MNOV delivered -13.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LENSAR ROEMediciNova ROELENSAR operating marginMediciNova operating marginLENSAR revenue growthMediciNova revenue growthLENSAR free cash flowMediciNova free cash flow
LENSAR & MediciNova appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.